
    
      The primary objective is to determine the noninferiority (NI) in the early clinical response
      rate of intravenous (IV) to oral 6 day TR-701 free acid (FA) compared with that of IV to oral
      10-day linezolid treatment at 48-72 hours after the first infusion of study drug in the
      intent-to-treat (ITT) analysis set in patients with acute bacterial skin and skin structure
      infections (ABSSSI).
    
  